On May 27, D-Wave Quantum declined 5.03% in regular trading, trading at $26.665/share, with trading volume of $214 million. The stock extended the previous session's pullback as selling pressure persisted.

On the news front, the decline represents a continuation of profit-taking following a sharp rally driven by the CHIPS and Science Act funding announcement. The company signed a preliminary agreement with the U.S. Department of Commerce to receive up to $100 million in funding to accelerate quantum computing R&D and commercialization. This catalyst propelled shares from approximately $19 on May 20 to nearly $30 by May 22, creating substantial unrealized gains that are now being unwound.

Compounding the selling pressure, D-Wave's Q1 earnings revealed significant fundamental weakness. Revenue came in at approximately $2.86 million, declining roughly 81% year-over-year, while operating expenses doubled to $56.5 million and net losses expanded to $18.36 million. With the policy catalyst fully priced in, the market is refocusing on the company's near-term financial challenges.

D-Wave Quantum is a quantum computing pioneer offering full-stack solutions including quantum computing systems, software, and services, with a focus on commercial-grade quantum application deployment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)